These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 28482390)
1. [Clinical analysis of 11 children with pancreatic cystic fibrosis]. Wang GL; Zhao CN; Zhou J; Yu FH; Shen HQ; Zhang J; Zhao SY; Xu XW Zhonghua Er Ke Za Zhi; 2017 May; 55(5):373-376. PubMed ID: 28482390 [No Abstract] [Full Text] [Related]
2. [Clinical phenotypes and genotypic spectrum of cystic fibrosis with pancreatic insufficiency in children]. Guo ZY; Chen JL; Wang LB; Qian LL Zhonghua Er Ke Za Zhi; 2022 Sep; 60(9):915-919. PubMed ID: 36038301 [No Abstract] [Full Text] [Related]
3. [Molecular diagnosis of two Chinese cystic fibrosis children and literature review]. Xu BP; Wang H; Zhao YH; Liu J; Yao Y; Feng XL; Shen KL Zhonghua Er Ke Za Zhi; 2016 May; 54(5):344-8. PubMed ID: 27143075 [TBL] [Abstract][Full Text] [Related]
4. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype. De Boeck K; Weren M; Proesmans M; Kerem E Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171 [TBL] [Abstract][Full Text] [Related]
6. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. FitzSimmons SC; Burkhart GA; Borowitz D; Grand RJ; Hammerstrom T; Durie PR; Lloyd-Still JD; Lowenfels AB N Engl J Med; 1997 May; 336(18):1283-9. PubMed ID: 9113931 [TBL] [Abstract][Full Text] [Related]
7. [Relationship between changes of increased amylase or lipase levels and pancreas injury in critically ill children]. National Research Coordination Group of the Critically Ill Children Secondary Pancreatic Injury Zhonghua Er Ke Za Zhi; 2016 Sep; 54(9):658-64. PubMed ID: 27596079 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study. Graff GR; Maguiness K; McNamara J; Morton R; Boyd D; Beckmann K; Bennett D Clin Ther; 2010 Jan; 32(1):89-103. PubMed ID: 20171415 [TBL] [Abstract][Full Text] [Related]
9. [Clinical characteristics and outcome of cystic fibrosis: report of 16 cases]. Khemiri M; Ben Rhouma A; Bouzid S; Messaoud T; Guesmi M; Hamzaoui M; Fattoum S; Khaldi F; Barsaoui S Tunis Med; 2008 Jun; 86(6):567-72. PubMed ID: 19216450 [TBL] [Abstract][Full Text] [Related]
10. The clinical and laboratory manifestations of Iranian patients with cystic fibrosis. Fallahi G; Najafi M; Farhmand F; Bazvand F; Ahmadi M; Ahmadi F; Eftekhari K; Khodad A; Motamed F; Khatami G; Aghamohammadi A; Rezaei N Turk J Pediatr; 2010; 52(2):132-8. PubMed ID: 20560247 [TBL] [Abstract][Full Text] [Related]
11. Effect of cimetidine and pancreatic enzymes on serum and fecal bile acids and fat absorption in cystic fibrosis. Boyle BJ; Long WB; Balistreri WF; Widzer SJ; Huang N Gastroenterology; 1980 May; 78(5 Pt 1):950-3. PubMed ID: 7380201 [TBL] [Abstract][Full Text] [Related]
12. Pancreatic enzyme replacement therapy dosing and nutritional outcomes in children with cystic fibrosis. Haupt ME; Kwasny MJ; Schechter MS; McColley SA J Pediatr; 2014 May; 164(5):1110-1115.e1. PubMed ID: 24560182 [TBL] [Abstract][Full Text] [Related]
13. Hemolytic anemia and edema as the initial signs in infants with cystic fibrosis. Consider this diagnosis even in absence of pulmonary symptoms. Dolan TF Clin Pediatr (Phila); 1976 Jul; 15(7):597-600. PubMed ID: 1277693 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic problems in cystic fibrosis - specific characteristics of a group of infants and young children diagnosed positive through neonatal screening, in whom cystic fibrosis had not been diagnosed. Woś H; Sankiewicz-Szkółka M; Więcek S; Kordys-Darmolińska B; Grzybowska-Chlebowczyk U; Kniażewska M Dev Period Med; 2015; 19(1):25-31. PubMed ID: 26003067 [TBL] [Abstract][Full Text] [Related]
15. Serum immunoreactive pancreatic lipase and cationic trypsinogen for the assessment of exocrine pancreatic function in older patients with cystic fibrosis. Cleghorn G; Benjamin L; Corey M; Forstner G; Dati F; Durie P Pediatrics; 1986 Mar; 77(3):301-6. PubMed ID: 3951910 [TBL] [Abstract][Full Text] [Related]
16. Omeprazole, a proton pump inhibitor, improves residual steatorrhoea in cystic fibrosis patients treated with high dose pancreatic enzymes. Proesmans M; De Boeck K Eur J Pediatr; 2003 Nov; 162(11):760-3. PubMed ID: 13680386 [TBL] [Abstract][Full Text] [Related]
17. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report. Walicka-Serzysko K; Sands D Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072 [TBL] [Abstract][Full Text] [Related]
18. [Aquagenic palmoplantar keratoderma in children with cystic fibrosis]. Weil B; Chaillou E; Troussier F; Pelatan C; Chiffoleau M; Darviot E; Chevalier MC; Martin L; Giniès JL Arch Pediatr; 2013 Dec; 20(12):1306-9. PubMed ID: 24210985 [TBL] [Abstract][Full Text] [Related]
19. [Cutaneous manifestations of cystic fibrosis in an infant: acrodermatitis enteropathica and gray hair]. Yarmuch GP; Chaparro RX; Fischer SC Rev Chil Pediatr; 2015; 86(1):52-5. PubMed ID: 26223399 [TBL] [Abstract][Full Text] [Related]